Characteristics | n = 178 |
---|---|
Survival time (days, mean (SD)) | 798.92 (760.64) |
Age (mean (SD)) | 59.19 (13.39) |
Gender (%) | |
 Female | 58 (32.6) |
 Male | 120 (67.4) |
Tumor grade (%) | |
 G1 | 21 (11.8) |
 G2 | 122 (68.5) |
 G3 | 35 (19.7) |
T stage (%) | |
 T1 | 24 (14.0) |
 T2 | 56 (32.7) |
 T3 | 41 (24.0) |
 T4 | 50 (29.2) |
N stage (%) | |
 N0 | 70 (42.7) |
 N1 | 24 (14.6) |
 N2 | 68 (41.5) |
 N3 | 2 (1.2) |
Clinical stage (%) | |
 Stage I–II | 54 (30.3) |
 Stage III–IV | 124 (69.7) |